CRP and cancer: Serum inflammatory markers and indices based on circulating immune cells and other laboratory values such as C-reactive protein (CRP) or lactate dehydrogenase (LDH) have been proposed as additional tools to predict response to treatment and clinical outcomes in various cancer types [12–14].